Correlation Between Milestone Pharmaceuticals and Vyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Vyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Vyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Vyne Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Vyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Vyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Vyne Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Vyne Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Milestone and Vyne is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Vyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vyne Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Vyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vyne Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Vyne Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Vyne Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Vyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 1.69 times less risky than Vyne Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Vyne Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 374.00 in Vyne Therapeutics on August 30, 2024 and sell it today you would lose (79.00) from holding Vyne Therapeutics or give up 21.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Vyne Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Vyne Therapeutics |
Milestone Pharmaceuticals and Vyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Vyne Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Vyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Vyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vyne Therapeutics will offset losses from the drop in Vyne Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Vyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Vyne Therapeutics vs. Bright Minds Biosciences | Vyne Therapeutics vs. HP Inc | Vyne Therapeutics vs. Intel | Vyne Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |